EPHA2 and colorectal carcinoma: In CRC, IGF2BP2 and IGF2BP3 stabilize their transcripts by interacting with m6A sites of Ephrin Type-A Receptor 2 (EphA2) and Vascular Endothelial Growth Factor (VEGF), respectively, stimulating vasculogenic mimicry formation.